Literature DB >> 2842042

Expression and modulation of a retrovirus-associated antigen by murine melanoma cells.

S P Leong1, J Muller, R A Yetter, E Gorelik, T Takami, V J Hearing.   

Abstract

The antigen recognized by the monoclonal antibody MM2-9B6 is specific for melanomas originating in C57BL/6 mice. It is expressed by three melanomas of independent origin and not by normal or fetal tissues, by a wide variety of other nonmelanoma tumors in C57BL/6 mice, or even by melanomas syngeneic to other strains of mice. We have demonstrated that the expression of the relevant antigen is dependent on the replication and budding of a B-tropic ecotropic murine retrovirus. The relationship between the expression of this virus and carcinogenic progression may yield important insights into the cascade of events leading to neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842042

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugates.

Authors:  A M Montgomery; M G Wing; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Sequence and insertion sites of murine melanoma-associated retrovirus.

Authors:  M Li; X Huang; Z Zhu; E Gorelik
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  Inhibition of VLA-4 and up-regulation of TIMP-1 expression in B16BL6 melanoma cells transfected with MHC class I genes.

Authors:  F Xu; T Carlos; M Li; O Sanchez-Sweatman; R Khokha; E Gorelik
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

4.  Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.

Authors:  E Gorelik; M Kim; L Duty; T Henion; U Galili
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

5.  Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.

Authors:  V Ramakrishna; A Eisenthal; Y Skornick; M Shinitzky
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

6.  Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice.

Authors:  Lasse Neukirch; Tea Kirkegaard Nielsen; Henriette Laursen; Joana Daradoumis; Christian Thirion; Peter Johannes Holst
Journal:  Oncotarget       Date:  2019-02-15

7.  Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice.

Authors:  Byong H Kang; Noor Momin; Kelly D Moynihan; Murillo Silva; Yingzhong Li; Darrell J Irvine; K Dane Wittrup
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

8.  Restoration of Endogenous Retrovirus Infectivity Impacts Mouse Cancer Models.

Authors:  Eleonora Ottina; Prisca Levy; Urszula Eksmond; Julia Merkenschlager; George R Young; Juliette Roels; Jonathan P Stoye; Thomas Tüting; Dinis P Calado; George Kassiotis
Journal:  Cancer Immunol Res       Date:  2018-08-24       Impact factor: 11.151

Review 9.  Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma.

Authors:  J Doukas; A Rolland
Journal:  Cancer Gene Ther       Date:  2012-10-05       Impact factor: 5.987

10.  Expression of a suppressive p15E-related epitope in colorectal and gastric cancer.

Authors:  S Foulds; C H Wakefield; M Giles; J Gillespie; J F Dye; P J Guillou
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.